These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23463940

  • 1. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.
    Pan J, Lau J, Mesak F, Hundal N, Pourghiasian M, Liu Z, Bénard F, Dedhar S, Supuran CT, Lin KS.
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):249-55. PubMed ID: 23463940
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.
    Lau J, Pan J, Zhang Z, Hundal-Jabal N, Liu Z, Bénard F, Lin KS.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3064-8. PubMed ID: 24878197
    [Abstract] [Full Text] [Related]

  • 3. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J, Zhang Z, Jenni S, Kuo HT, Liu Z, Vullo D, Supuran CT, Lin KS, Bénard F.
    Mol Pharm; 2016 Mar 07; 13(3):1137-46. PubMed ID: 26866675
    [Abstract] [Full Text] [Related]

  • 4. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
    Lau J, Liu Z, Lin KS, Pan J, Zhang Z, Vullo D, Supuran CT, Perrin DM, Bénard F.
    J Nucl Med; 2015 Sep 07; 56(9):1434-40. PubMed ID: 26205302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties.
    Iikuni S, Okada Y, Shimizu Y, Watanabe H, Ono M.
    Mol Pharm; 2021 Mar 01; 18(3):966-975. PubMed ID: 33472371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of 99mTc-sulfonamide and sulfocoumarin derivatives for imaging carbonic anhydrase IX expression.
    Nakai M, Pan J, Lin KS, Thompson JR, Nocentini A, Supuran CT, Nakabayashi Y, Storr T.
    J Inorg Biochem; 2018 Aug 01; 185():63-70. PubMed ID: 29778927
    [Abstract] [Full Text] [Related]

  • 11. Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors.
    More KN, Lee JY, Kim DY, Cho NC, Pyo A, Yun M, Kim HS, Kim H, Ko K, Park JH, Chang DJ.
    Bioorg Med Chem Lett; 2018 Mar 01; 28(5):915-921. PubMed ID: 29422388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX.
    Iikuni S, Tanimura K, Watanabe H, Shimizu Y, Saji H, Ono M.
    Mol Pharm; 2019 Apr 01; 16(4):1489-1497. PubMed ID: 30892905
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK, Bansal S, Lohan S, Modak V, Chaudhary A, Tiwari A.
    Eur J Med Chem; 2013 Aug 02; 66():372-9. PubMed ID: 23827177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A, Závada J, Parkkila S, Kaluz S, Kaluzová M, Rajcáni J, Pastorek J, Pastoreková S.
    Int J Cancer; 2003 Jul 20; 105(6):873-81. PubMed ID: 12767076
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT.
    Bioorg Med Chem Lett; 2004 Feb 23; 14(4):869-73. PubMed ID: 15012984
    [Abstract] [Full Text] [Related]

  • 20. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.
    Sharma A, Tiwari M, Supuran CT.
    J Enzyme Inhib Med Chem; 2014 Apr 23; 29(2):292-6. PubMed ID: 23488741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.